Sudden Unexplained Death in Childhood (SUDC) Registry
Launched by NYU LANGONE HEALTH · Apr 6, 2017
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
The Sudden Unexplained Death in Childhood (SUDC) Registry is a study aimed at understanding why some children between 11 months and 18 years old die suddenly and unexpectedly, often without any clear explanation. Researchers are looking at the medical histories, circumstances, and other details surrounding these tragic cases to identify potential risk factors and causes. This knowledge could help develop ways to prevent such deaths in the future.
To participate in this study, children who have died suddenly and unexpectedly may be eligible, especially if there was no clear cause found after an autopsy. Family members of these children, such as parents and siblings, may also be invited to join, particularly if there's a history of heart or neurological conditions in the family. Participants can expect to share their experiences and any available medical information, which will contribute to the understanding of these cases. The study is currently recruiting participants and aims to make a meaningful impact on child health and safety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Retrospective SUDC Cases
- • 11months to 18 years of age.
- • Subjects whose cause of death was sudden and unexplained-"Postinfancy SIDS," "Sudden Death of Childhood," "Undetermined," "Late SIDS," a vague description of symptoms of "undetermined etiology," or a diagnosis acknowledged to be speculative by the prosecting pathologist
- • If the retrospective case has banked DNA specimens.
- • Prospective SUDC Cases
- • SUDC cases, parents and eligible family members from 11months-100 years of age.
- • SUDC Subjects whose death was sudden and unexplained after the initial autopsy, and in whom a scene investigation and full autopsy was performed.
- • Family Members Subjects
- • If the SUDC case has DNA viable specimens, family members will be asked if they would also like to participate in the DNA portion. One or both biological parents if willing and able will be considered as a family subject.
- • Biological siblings and second degree relatives from age of 0-100 years of age that have had a history or currently have a heart condition and/or neurology condition.
- Exclusion Criteria:
- • SUDC Subjects
- • Subjects that are younger than 11months or older than 18 years of age will be excluded as a SUDC case.
- • Prospective SUDC cases of apparent suicide, homicide, and accident where the external cause was the obvious and only reason for the death will be excluded from this study.
- • Family Member Subjects Any siblings or second degree family relatives that did not have a history or current heart or neurology condition will not be able to enroll in the study.
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Orrin Devinsky, MD
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials